These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 14662401)

  • 1. Storage and voiding symptoms: pathophysiologic aspects.
    Andersson KE
    Urology; 2003 Nov; 62(5 Suppl 2):3-10. PubMed ID: 14662401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential mechanisms of action of superselective alpha(1)-adrenoceptor antagonists.
    Price D
    Eur Urol; 2001; 40 Suppl 4():5-11. PubMed ID: 11786674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LUTS treatment: future treatment options.
    Andersson KE
    Neurourol Urodyn; 2007 Oct; 26(6 Suppl):934-47. PubMed ID: 17696154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha1-adrenoceptors and bladder function.
    Andersson K
    Eur Urol; 1999; 36 Suppl 1():96-102. PubMed ID: 10393481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Gallegos PJ; Frazee LA
    Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.
    Jhang JF; Liao CH; Kuo HC
    Int J Clin Pract; 2014 Jun; 68(6):743-8. PubMed ID: 24471413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early treatment of benign prostatic hyperplasia: implications for reducing the risk of permanent bladder damage.
    Tubaro A; Carter S; Trucchi A; Punzo G; Petta S; Miano L
    Drugs Aging; 2003; 20(3):185-95. PubMed ID: 12578399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system.
    Andersson KE; Gratzke C
    Nat Clin Pract Urol; 2007 Jul; 4(7):368-78. PubMed ID: 17615548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and video urodynamic characteristics of adult women with dysfunctional voiding.
    Chen YC; Kuo HC
    J Formos Med Assoc; 2014 Mar; 113(3):161-5. PubMed ID: 24630033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of abdominal straining in men with lower urinary tract symptoms.
    Reynard JM; Peters TJ; Lamond E; Abrams P
    Br J Urol; 1995 Feb; 75(2):148-53. PubMed ID: 7531591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of alpha1-adrenoceptor antagonists in lower urinary tract symptoms: beyond benign prostatic hyperplasia.
    Nickel JC
    Urology; 2003 Sep; 62(3 Suppl 1):34-41. PubMed ID: 12957198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of alpha-adrenergic and muscarinic antagonists for the treatment of voiding dysfunction.
    Ruggieri MR; Braverman AS; Pontari MA
    J Urol; 2005 Nov; 174(5):1743-8. PubMed ID: 16217275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life.
    Djavan B
    Urology; 2003 Sep; 62(3 Suppl 1):6-14. PubMed ID: 12957195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology: the varieties of bladder overactivity.
    Mostwin JL
    Urology; 2002 Nov; 60(5 Suppl 1):22-6; discussion 27. PubMed ID: 12493346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings.
    Hyman MJ; Groutz A; Blaivas JG
    J Urol; 2001 Aug; 166(2):550-2; discussion 553. PubMed ID: 11458066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower urinary tract symptoms/benign prostatic hyperplasia: maintaining symptom control and reducing complications.
    O'Leary MP
    Urology; 2003 Sep; 62(3 Suppl 1):15-23. PubMed ID: 12957196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower urinary tract symptoms in the older male.
    Hsieh K; Taylor JA; Albertsen PC
    Conn Med; 2003 Sep; 67(8):487-90. PubMed ID: 14587129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of ultrasound estimated bladder weight during tamsulosin treatment in patients with benign prostatic enlargement.
    Sironi D; Levorato CA; Deiana G; Borgonovo G; Belussi D; Ranieri A; Lembo A
    Arch Ital Urol Androl; 2002 Jun; 74(2):90-4. PubMed ID: 12161944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.